Andreas Schmidt (Phd.) Email & Phone Number

Munich, BY, DE

Cologne, NRW, DE

Berlin, DE

Lugano, Ticino, CH

Interactively visualize and analyze your omics data

Heidelberg, Baden-Württemberg, DE

Towards a healthier future through entrepreneurship in life sciences. DKFZ, DZNE,Max Delbrück Center, HZDR, Helmholtz München, Helmholtz Infektionsforschung

Munich, Bavaria, DE

Empowering entrepreneurs to reimagine the way we live and work

San Carlos, California, US

Phinomics uses circular DNA, an early marker of genetic and environmental change, to diagnose disease and radically improve human health. By isolating and sequencing the circular genome ("the circulome", a term we coined), we solve a genetic puzzle that unlocks a universal “stage-zero” diagnostic for disease. At scale, circulome data will revolutionize.

Swiss based startup generating on-line, automated and real-time cell analysis. Innovative processes for cell expansion and cell therapy manufacturing.

Singapore, Singapore, SG

Duke-NUS Medical School is a collaboration between Duke University and the National University of Singapore providing excellence in education, medicine, research and health technology translation.

Toronto, Ontario, CA

Creative Destruction Lab (CDL) is a nonprofit organization that delivers an objectives-based program for massively scalable, seed-stage, science- and technology-based companies.

Budapest, HU

EIT Health and the European investment Fund (EIF) are partnering to operate the Venture Centre of Excellence (VCOE), a public-private co-investment programme to empower finance for European health small and medium size enterprises (SMEs).

Singapore, SG

Scaling innovative deep tech businesses between Singapore and Germany

Frankfurt Am Main, Hessen, DE

Aescuvest and EIT Health join each other to unite two big supporters of new technologies and ideas in healthcare. Together we operate the leading platform to foster and crowdfund smart healthcare ideas. This independent launch pad offers digital financing strategies to European start-up-companies and an above-average impact and profit share to European.

Singapore, Singapore, SG

Moving Mountains. Schmidt Deng Ventures is creating, supporting and funding a new generation of biotech and IT companies being deeply rooted in the technology and finance ecosystems of both Asia and Europe. A special emphasis of SDV lies on Singapore, Taiwan, China and Germany.

Proteona - now part of Singleron Biotechnologies - is a Venture Capital backed precision medicine company focusing on oncology and immunology. The company is headquartered in Singapore and provides single cell proteogenomic analysis on AI-based methods to design the cancer trials, patient stratification and therapy selection of the future.

AYOXXA Biosystems GmbHAYOXXA Inc.AYOXXA Pte. Ltd.AyoxxA is a biotech company commercializing innovative technology developed at the National University of Singapore (NUS). AyoxxA’s patented technology platform is producing a new generation of biochips – merging biology with IT. This allows the biochip to accumulate large numbers of applications – measuring.

München, Bavaria, DE

https://www.fraunhofer.de/en.html

Singapore, Singapore, SG

The "Catalyst Program" was established to nurture and mentor entrepreneurs. "Catalysts" are selected from the Singapore and Boston business community who have expertise working with emerging technology companies.

Fürth, Bayern, DE

The Challenge: Creating TEN international startup companies from within the GAIN network.

Berkeley, CA, US

UC Berkeley USA & U of Cologne, Germany

Bonn, Nordrhein-Westfalen, DE

Basel, CH

Evanston, IL, US

Doctor'S Degree, Immunology Genetics

Management Of Technology China Fellow

Diploma, Immunology, Genetics, Biochemistry, Pharmacology

Genetics, Biochemistry

Biology